Middleton, WI, United States of America

Hongzhi Zou

This inventor holds 47 USPTO granted patents and 16 published patent applications, plus 7 CIPO patents and 10 EPO patents, primarily in Nucleic Acid Detection. Top assignees: Exact Sciences Corporation, Mayo Foundation for Medical Education and Research, Exact Sciences Development Company, LLC. Active years: 2010-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hongzhi Zou. Retrieved from https://idiyas.com/inventor/hongzhi-zou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 47 

% Patents Active = 97.9


 

Average Co-Inventor Count = 5.1

ph-index = 9

Forward Citations = 352(Granted Patents)


Location History:

  • Rochester, MN (US) (2010)
  • Middleton, WI (US) (2013 - 2024)

Company Filing History:


Years Active: 2010-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Nucleic Acids
Mutation Detection
KRAS Assay
Methylation Assay
Colorectal Cancer
Digital Sequence Analysis
Cleavage Assay
Neoplasm Detection
Exfoliated Epithelia
Fecal Blood Marker
Multiplexed Assays
Real Time Analysis
47 patents (USPTO):Explore Patents

Certainly! Here is the article about inventor Hongzhi Zou:

Title: Innovator Spotlight: Hongzhi Zou - Pioneering Advancements in Genetic Analysis

Introduction:

Hongzhi Zou, a distinguished inventor based in Middleton, WI (US), has made significant contributions to the field of genetic analysis with 42 patents to his name. His pioneering work in digital sequence analysis of DNA methylation and mutation detection assays has revolutionized the way we approach cancer diagnostics and research.

Latest Patents:

One of Zou's latest patents focuses on digital sequence analysis of DNA methylation, offering methods and compositions for determining specific methylation patterns indicative of adenoma and carcinoma. By analyzing defined CpG loci that are coordinately methylated in DNAs from cancer and adenoma samples, Zou's invention enables the design of assays for early detection and treatment of these diseases. Another breakthrough patent involves a mutation detection assay, which amplifies a product from a sample containing wild type and mutant copies of a genomic locus with a point mutation. This method, coupled with a flap assay using an invasive oligonucleotide, allows for precise detection of genetic mutations.

Career Highlights:

Zou has left an indelible mark on the field of genetic analysis through his tenure at renowned institutions such as Exact Sciences Corporation and Mayo Foundation for Medical Education and Research. His innovative approaches have paved the way for more efficient and accurate genetic testing methods, leading to improved patient outcomes and advancements in medical research.

Collaborations:

Throughout his career, Zou has collaborated with esteemed colleagues such as Graham P Lidgard and Michael J Domanico. Together, they have worked tirelessly to push the boundaries of genetic analysis and develop cutting-edge technologies that have the potential to shape the future of healthcare.

Conclusion:

Inventor Hongzhi Zou's relentless pursuit of innovation and dedication to advancing the field of genetic analysis have established him as a trailblazer in the realm of medical technology. His inventions continue to inspire and drive progress in the fight against cancer and other genetic disorders, leaving an enduring legacy in the scientific community.

I hope this article provides you with valuable insights into the groundbreaking work of inventor Hongzhi Zou. If you have any more questions or need further information, feel free to ask!

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…